Physician profile

Syed Alam

Pulmonary Disease · Bakersfield, CA

NPI 1073541512

$12,745.34

in general payments reported to CMS, 2019-2025

61 companies · $946 in 2025

The $946 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,167.06
Education$183.32

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $2,920.19 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Astrazeneca Pharmaceuticals LP $1,984.39 2019-2025 Airsupra, Breztri, Tezspire
Boehringer Ingelheim Pharmaceuticals, INC. $943.04 2019-2025 Stiolto Respimat, Ofev, Spiriva Respimat
Actelion Pharmaceuticals US, INC. $826.81 2019-2024 Uptravi, Opsumit
Philips North America LLC $439.07 2019-2024 (8874) Incourage
Novo Nordisk INC $377.76 2019-2024 Rybelsus, Ozempic
Grifols USA, LLC $328.66 2019-2025 Prolastin-C Liquid
Insmed, INC. $291.80 2020-2025 Arikayce, Brinsupri
Astellas Pharma US INC $284.76 2019-2025 Cresemba
Daiichi Sankyo INC. $247.33 2020-2023 Injectafer
United Therapeutics Corporation $225.03 2019-2024 Tyvaso
Janssen Pharmaceuticals, INC $219.72 2019-2022
Amgen INC. $207.68 2020-2025 Tezspire
Merck Sharp & Dohme LLC $203.44 2019-2025 Winrevair
Electromed, INC. $196.37 2021-2025 Smartvest
Show all 61 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $194.23 2020-2024
Novartis Pharmaceuticals Corporation $193.83 2019-2023
Bayer Healthcare Pharmaceuticals INC. $191.33 2019-2023
Advanced Respiratory, INC $181.45 2019-2020
Sunovion Pharmaceuticals INC. $166.57 2019-2020
Takeda Pharmaceuticals U.S.A., INC. $149.84 2019-2025 Glassia
Pulmonx Corporation $144.48 2019-2022
Regeneron Healthcare Solutions, INC. $137.86 2019-2024 Dupixent
Baxter Healthcare $122.74 2023-2025 Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System
Mylan Specialty L.P. $110.21 2020-2024 Yupelri
Resmed Corp $93.48 2019
Otsuka America Pharmaceutical, INC. $92.79 2021-2023 Abilify Maintena, Nuedexta
Mayne Pharma Commercial LLC $89.82 2020-2022
Genzyme Corporation $74.60 2021-2022
Allergan, INC. $71.51 2019-2020
Lilly USA, LLC $66.04 2019-2025
Ironwood Pharmaceuticals, INC $65.18 2020-2021
Tanabe Pharma America, INC. $62.57 2020-2023
Exact Sciences Corporation $61.91 2023-2025 Cologuard Collection Kit
Avanir Pharmaceuticals, INC. $60.19 2019
Abbvie INC. $58.55 2021-2022
Kowa Pharmaceuticals America, INC. $54.22 2019-2020
Arbor Pharmaceuticals, INC. $53.30 2020-2021
Phadia US INC. $51.27 2021-2024 Immunocap
Boston Scientific Corporation $49.49 2019-2023
Medtronic, INC. $40.38 2023-2025 Illumisite
Vifor Pharma, INC. $34.75 2024 Zemaira, Veltassa
Inari Medical, INC. $32.98 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Axsome Therapeutics, INC. $30.21 2023-2025 Sunosi, Auvelity
Teva Pharmaceuticals USA, INC. $26.11 2019
Csl Behring $25.90 2019
Abiomed $25.00 2024 Impella
Harmony Biosciences LLC $23.46 2022
Horizon Therapeutics Plc $22.56 2020
Inspire Medical Systems, INC. $22.08 2024 Inspire
Pinnacle Biologics, INC $19.97 2020
Optinose US, INC. $19.61 2024
Stryker Corporation $17.98 2025 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Sanofi-Aventis U.S. LLC $17.05 2020
Veran Medical Technologies, INC. $16.33 2020
Viatris Specialty LLC $14.32 2025 Yupelri
Amylyx Pharmaceuticals, INC. $14.17 2023 Relyvrio
Lundbeck LLC $13.58 2025 Rexulti
Gilead Sciences, INC. $12.97 2019
Zyla Life Sciences, INC. $11.80 2019
Ceribell, INC. $10.62 2023 Ceribell Rapid Response Eeg

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Syed Alam

$12,745.34

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $946 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/320488/syed-alam

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.